NCT05941650

Brief Summary

To evaluate whether there is clinical improvement through the scales (Bristol, IBS severity score, and IBS quality of life) in women with irritable bowel syndrome after administration of SC-FOS (short-chain fructooligosaccharides).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

December 2, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2025

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2025

Completed
Last Updated

February 5, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

July 3, 2023

Last Update Submit

February 1, 2024

Conditions

Keywords

Irritable Bowel SyndromeSC-FOSPrebiotics

Outcome Measures

Primary Outcomes (3)

  • Score of IBS-QOL

    Score obtained in the questionnaire Irritable Bowel Syndrome - Quality of Life

    10 days

  • Score of Bristol Scale

    Score obtained by Stool Consistency Bristol Scale The seven types of stool are: Type 1: Separate hard lumps, like nuts (difficult to pass) Type 2: Sausage-shaped, but lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage or snake, smooth and soft (average stool) Type 5: Soft blobs with clear cut edges Type 6: Fluffy pieces with ragged edges, a mushy stool (diarrhea) Type 7: Watery, no solid pieces, entirely liquid (diarrhea) Types 1 and 2 indicate constipation, with 3 and 4 being the ideal stools as they are easy to defecate while not containing excess liquid, 5 indicating lack of dietary fiber, and 6 and 7 indicate diarrhoea.

    10 days

  • Score of IBS-SSS

    Score obtained in the questionnaire Irritable Bowel Syndrome - Severity Scoring System

    10 days

Study Arms (2)

Short Chain Fructooligosaccharides Group

EXPERIMENTAL

This group will receive Short-Chain Fructooligosaccharides at a dose of 12 gr. every 24 hours for 10 days, diluted in 250 ml

Dietary Supplement: Short Chain Fructooligosaccharides

Group

PLACEBO COMPARATOR

This group will receive Corn Starch as a Placebo control 12 gr. every 24 hours for 10 days, diluted in 250 ml

Other: Corn Starch

Interventions

The intervention will receive Short-Chain Fructooligosaccharides at a dose of 12 gr. every 24 hours diluted in 250 ml of water.

Also known as: Prebiotics
Short Chain Fructooligosaccharides Group

This group will receive 12 g of corn starch as a control group.

Also known as: Placebo
Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female sex
  • Age 18 to 65 years
  • Irritable Bowel Syndrome diagnosed by Rome Criterion
  • Useful enteral feeding

You may not qualify if:

  • Recent gastrointestinal disease \< 2 weeks different to IBS
  • Previous consumption of SC-FOS
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Irritable Bowel Syndrome

Interventions

PrebioticsStarch

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Dietary FiberDietary CarbohydratesCarbohydratesPolysaccharides, BacterialPolysaccharidesFoodDiet, Food, and NutritionPhysiological PhenomenaDietary SupplementsFood and BeveragesGlucansBiopolymersPolymersMacromolecular Substances

Study Officials

  • Luis B Enríquez Sánchez

    Universidad Autonoma de Chihuahua

    STUDY DIRECTOR

Central Study Contacts

Carolina Martinez Loya

CONTACT

Ruth S Favela Ortiz

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective study, randomized single blind clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Médico Pasante de Servicio Social

Study Record Dates

First Submitted

July 3, 2023

First Posted

July 12, 2023

Study Start

December 2, 2024

Primary Completion

May 10, 2025

Study Completion

May 30, 2025

Last Updated

February 5, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

The data obtained from this research study will be available if requested once the study is finalized.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The data will be available for up to five years since completion of the study.
Access Criteria
The request for the data will be by e-mail.